Ciulla, Thomas A.

Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis

Yeh, S., Khurana, R. N., Shah, M., Henry, C. R., Wang, R. C., Kissner, J. M., Ciulla, T. A., & Noronha, G. (2020) · Ophthalmology

Ocular Diseases and Behçet’s SyndromeRetinal Diseases and Treatments

Cited by 191

Real-world outcomes of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration in the United States

Ciulla, T. A., Huang, F., Westby, K., Williams, D. F., Zaveri, S., & Patel, S. C. (2018) · Ophthalmology Retina

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 115

Innovative therapies for neovascular age-related macular degeneration

Al-Khersan, H., Hussain, R. M., Ciulla, T. A., & Dugel, P. U. (2019) · Expert Opinion on Pharmacotherapy

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 114

Suprachoroidal delivery of viral and nonviral gene therapy for retinal diseases

Kansara, V., Muya, L., Wan, C.-R., & Ciulla, T. A. (2020) · Journal of Ocular Pharmacology and Therapeutics

Retinal Development and DisordersRNA Interference and Gene Delivery

Cited by 84

Gene therapy for age-related macular degeneration

Moore, N. A., Bracha, P., Hussain, R. M., Morral, N., & Ciulla, T. A. (2017) · Expert Opinion on Biological Therapy

Retinal Diseases and TreatmentsRetinal Development and Disorders

Cited by 63

Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development

Ciulla, T. A., Hussain, R. M., Berrocal, A. M., & Nagiel, A. (2020) · Expert Opinion on Biological Therapy

Retinal Development and DisordersVirus-based gene therapy research

Cited by 59

Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes

Chung, S. H., Mollhoff, I. N., Mishra, A., Sin, T.-N., Ngo, T., Ciulla, T., Sieving, P., Thomasy, S. M., & Yiu, G. (2021) · Human Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 57

Stargardt macular dystrophy and evolving therapies

Hussain, R. M., Ciulla, T. A., Berrocal, A. M., Gregori, N. Z., Flynn, H. W., & Lam, B. L. (2018) · Expert Opinion on Biological Therapy

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 56

Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema

Barakat, M. R., Wykoff, C. C., Gonzalez, V., Hu, A., Marcus, D., Zavaleta, E., & Ciulla, T. A. (2021) · Ophthalmology Retina

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 55

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Altaweel, M. M., Daniel, E., Martin, D. F., Mittra, R. A., Grunwald, J. E., Lai, M. M., Melamud, A., Morse, L. S., Huang, J., Ferris, F. L., et al. (2015) · Ophthalmology

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 51

Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques

Kovacs, K. D., Ciulla, T. A., & Kiss, S. (2022) · Expert Opinion on Biological Therapy

Retinal Development and DisordersVirus-based gene therapy research

Cited by 20